Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY: CI )

347.62 +1.54 (+0.44%)
Streaming Delayed Price Updated: 2:09 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cigna Corp

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
My Abilene Brain NeuroStar TMS Therapy Provides Effective Alternative Treatment for Major Depressive Disorder
My Abilene Brain Center is pleased to introduce NeuroStar TMS Therapy, a noninvasive and medication-free solution for Major Depressive Disorder (MDD). Utilizing transcranial magnetic stimulation (TMS),... 
Via Newsworthy
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Via Benzinga
$100 Invested In Cigna Group 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
Cigna Group (NYSE: CI) shares were rising in early trading on Monday after the company reported its fourth-quarter results. 
Via Benzinga
These Analysts Revise Their Forecasts On Cboe Global Markets Following Q4 Results
Cboe Global Markets, Inc. (NYSE: CBOE) reported better-than-expected fourth-quarter earnings on Friday. 
Via Benzinga
Cigna Outperforms In Q4 2023: Reports $51.1 Billion Revenue And $6.79 EPS
The Cigna Group reported an adjusted EPS of $6.79 and total revenues of $51.1 billion for the fourth quarter of 2023. 
Via Talk Markets
Assessing Cigna Group: Insights From 8 Financial Analysts
Via Benzinga
Earnings Preview For Cigna Group
Via Benzinga
How Is The Market Feeling About Cigna Group?
Via Benzinga
Cigna Analysts Increase Their Forecasts After Upbeat Earnings
Cigna Corporation (NYSE: CI) reported better-than-expected fourth-quarter results and issued a strong revenue outlook on Friday. 
Via Benzinga
Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 3
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Jan. 29 through Feb. 2. 
Via Talk Markets
Cigna Group (CI) Q4 2023 Earnings Call Transcript
CI earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Stocks Notch 4th Straight Positive Week Driven By Tech, Meta Shines, Bonds Tank On Hot Jobs Data: What's Driving Markets Friday?
US stock market sees fourth consecutive week of gains, driven by strong tech earnings and labor market. Total market value surpasses $12.9 trillion. 
Via Benzinga
$100 Invested In Cigna Group 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Clorox Posts Upbeat Earnings, Joins Cigna, Deckers Outdoor And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Dow Jones falling over 100 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Health Insurance Plan Provider Cigna Stock Trading Higher Today?
Cigna's robust Q4 2023 performance with $51.15 billion in sales, up 12% Y/Y. Dive into the growth of Cigna Healthcare, Evernorth Health Services. 
Via Benzinga
Nasdaq Futures Climb As Meta, Amazon Gains Offset Apple Slide: Analyst Points to 2 Factors Reinforcing Bullish Outlook This Year
Stock futures are pointing upwards on Friday as traders assess earnings reports from Meta Platforms, Inc. 
Via Benzinga
Paying Too Much for Insurance? Nationwide PPO Health Insurance Can Help
Via GetFeatured
Earnings Scheduled For February 2, 2024
Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion. 
Via Benzinga
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market
Aging is an inevitability, as much as we try to deny it. Under this context, these AgeTech stocks may prove quite relevant. 
Via InvestorPlace
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Scott Integrated Pain Management Offers Innovative Ketamine Treatment for Complex Regional Pain Syndrome (CRPS)
Scott Integrated Pain Management is a renowned healthcare facility specializing in chronic pain management. They offer innovative treatments, personalized care, and a compassionate approach to... 
Via Newsworthy
Fortune 100 Giant Tyson Foods Breaks Ties With CVS Caremark, Marks Shift Towards Transparent Pharmacy Benefit Managers
Tyson Foods shifts from CVS Caremark to startup Rightway, targeting a 15% reduction in pharmacy costs. Explore Tyson's move and its impact on the pharmacy benefits landscape. 
Via Benzinga
Affordable Care Act Enrollment Highest Since Inception: Obamacare Enrollment Witnesses 31% Jump in 2024
Historic milestone in healthcare: 21.3M Americans enroll in Obamacare, a 31% increase from last year. Act now, open enrollment persists in select states until January 31. 
Via Benzinga
Humana Blames Medicare Advantage As Stock Falls After Larger Than Expected Quarterly Loss, Grim Outlook
Humana faces challenges as Q4 2023 earnings disappoint. Adjusted EPS loss at $(0.11), revenue at $25.73 billion. 
Via Benzinga
Humana Dives On Huge 2024 Earnings Warning
The health insurer says earnings will be barely half of estimates. 
Via Investor's Business Daily
TMS Therapy Offers Hope for Patients with Major Depressive Disorder in Abilene, TX
Abilene Brain Center introduces a cutting-edge treatment for Major Depressive Disorder (MDD) with NeuroStar TMS Therapy. This non-invasive procedure, utilizing Transcranial Magnetic Stimulation (TMS),... 
Via Newsworthy
Affordable Care Act North Dakota: Every Health Group Unlocking Healthcare Horizons in the Region
Via GetFeatured
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.